These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 8420211

  • 1. Is the decreasing responsiveness of axial motor symptoms to L-dopa in elderly parkinsonian patients related to age-associated nonparkinsonian pathologies?
    Ransmayr G, Künig G, Neubauer M, Wagner M, Bösch S, Kreczy-Kleedorfer B.
    Adv Neurol; 1993; 60():685-9. PubMed ID: 8420211
    [No Abstract] [Full Text] [Related]

  • 2. Early detection of L-dopa response in parkinsonian patients with a standardized tracking test.
    Albani C, Buck A.
    Adv Neurol; 1993; 60():386-9. PubMed ID: 8420158
    [No Abstract] [Full Text] [Related]

  • 3. Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease. Improvement by the dopamine agonist apomorphine.
    Rascol OJ, Sabatini U, Chollet F, Montastruc JL, Marc-Vergnes JP, Rascol A.
    Adv Neurol; 1993; 60():419-21. PubMed ID: 8420165
    [No Abstract] [Full Text] [Related]

  • 4. Risk factors for motor response complications in L-dopa-treated parkinsonian patients.
    Peppe A, Dambrosia JM, Chase TN.
    Adv Neurol; 1993; 60():698-702. PubMed ID: 8420213
    [No Abstract] [Full Text] [Related]

  • 5. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
    Reddy S, Factor SA, Molho ES, Feustel PJ.
    Mov Disord; 2002 Jul; 17(4):676-81. PubMed ID: 12210856
    [Abstract] [Full Text] [Related]

  • 6. The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates.
    Hansard MJ, Smith LA, Jackson MJ, Cheetham SC, Jenner P.
    Mov Disord; 2004 Jan; 19(1):15-21. PubMed ID: 14743355
    [Abstract] [Full Text] [Related]

  • 7. Striatal dopaminoceptive system changes and motor response complications in L-dopa-treated patients with advanced Parkinson's disease.
    Chase TN, Engber TM, Mouradian MM.
    Adv Neurol; 1993 Jan; 60():181-5. PubMed ID: 8420133
    [No Abstract] [Full Text] [Related]

  • 8. Portable device for quantifying parkinsonian wrist rigidity.
    Caligiuri MP.
    Mov Disord; 1994 Jan; 9(1):57-63. PubMed ID: 7908119
    [Abstract] [Full Text] [Related]

  • 9. Clinical features and medical treatment of Parkinson's disease in patient groups selected in accordance with age at onset.
    Pantelatos A, Fornadi F.
    Adv Neurol; 1993 Jan; 60():690-7. PubMed ID: 8420212
    [Abstract] [Full Text] [Related]

  • 10. Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis.
    Merello M, Nouzeilles MI, Arce GP, Leiguarda R.
    Mov Disord; 2002 Jul; 17(4):795-8. PubMed ID: 12210878
    [Abstract] [Full Text] [Related]

  • 11. Single-dose L-dopa response in early Parkinson's disease: measurements with optoelectronic recording technique.
    Johnels B, Ingvarsson PE, Holmberg B, Matousek M, Steg G.
    Mov Disord; 1993 Jul; 8(1):56-62. PubMed ID: 8419808
    [Abstract] [Full Text] [Related]

  • 12. Clinical observations in early and late onset Parkinson's disease.
    Bostantjopoulou S, Logothetis J, Katsarou Z, Mentenopoulos G.
    Funct Neurol; 1991 Jul; 6(2):145-9. PubMed ID: 1916456
    [Abstract] [Full Text] [Related]

  • 13. Longitudinal study of the motor response to levodopa in Parkinson's disease.
    Clissold BG, McColl CD, Reardon KR, Shiff M, Kempster PA.
    Mov Disord; 2006 Dec; 21(12):2116-21. PubMed ID: 17029259
    [Abstract] [Full Text] [Related]

  • 14. Dopa-unresponsive pure akinesia or freezing. A condition within a wide spectrum of PSP?
    Imai H, Nakamura T, Kondo T, Narabayashi H.
    Adv Neurol; 1993 Dec; 60():622-5. PubMed ID: 8420201
    [No Abstract] [Full Text] [Related]

  • 15. Pathophysiology of parkinsonian motor abnormalities.
    Wichmann T, DeLong MR.
    Adv Neurol; 1993 Dec; 60():53-61. PubMed ID: 8420185
    [No Abstract] [Full Text] [Related]

  • 16. Hypokinesia in Parkinson's disease: influence of age, disease severity, and disease duration.
    van Hilten JJ, Braat EA, van der Velde EA, Middelkoop HA, van Dijk JG, Lighart GJ, Roos RA.
    Mov Disord; 1995 Jul; 10(4):424-32. PubMed ID: 7565821
    [Abstract] [Full Text] [Related]

  • 17. Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients.
    Limousin P, Pollak P, Hoffmann D, Benazzouz A, Perret JE, Benabid AL.
    Mov Disord; 1996 May; 11(3):231-5. PubMed ID: 8723137
    [Abstract] [Full Text] [Related]

  • 18. Nosological concept of juvenile parkinsonism with reference to the dopa-responsive syndrome.
    Yokochi M.
    Adv Neurol; 1993 May; 60():548-52. PubMed ID: 8420189
    [No Abstract] [Full Text] [Related]

  • 19. [Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease].
    Eichhorn TE, Schrag A, Trenkwalder C, Selzer R, Kohnen R, Oertel WH, Poewe W.
    Nervenarzt; 1995 Dec; 66(12):933-41. PubMed ID: 8584079
    [Abstract] [Full Text] [Related]

  • 20. Comparison of efficacy of lisuride hydrogen maleate with increased doses of levodopa in parkinsonian patients.
    Rabey JM, Treves T, Streifler M, Korczyn AD.
    Adv Neurol; 1987 Dec; 45():569-72. PubMed ID: 3825734
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.